Kang, Yaxin
Chang, Lele
Lin, Huaqin
Liu, Jing
Wang, Cong
Lu, Huaiwu
Xu, Qin
Funding for this research was provided by:
Natural Science Foundation of Fujian Province (2023J011273, 2024J011099)
Joint Funds for the National Clinical Key Specialty Construction Program (F2326Y-YZK08-01)
oint Funds for the innovation of science and Technology, Fujian province (2023Y9449)
Article History
Received: 24 September 2025
Accepted: 12 November 2025
First Online: 24 November 2025
Declarations
:
: This study was approved by the Institutional Review Board at Fujian Provincial Cancer Hospital (Number: K2024-206–01) and compliant with the Declaration of Helsinki. All patients provided written informed consent before enrollment.
: Not applicable.
: The authors declare no competing interests.